GliSODin provides a safe, effective and unique strategy for enhancing natural cellular defences which are known to decline during illness or with ageing. Clinical trials show that GliSODin pro-motes health and wellbeing by boosting circulating levels of antioxidant defences and helping re-duce oxidative damage.

GliSODin is a double-patented Cucumis melo melon extract combined with a small amount of gliadin biopolymer. GliSODins Nutrigenomic property is uniquely conferred by the presences of this gliadin biopolymer. This gliadin protects GliSODin from gastric degradation. Made in Australia under license from Laboratories ISOCELL NUTRA; GliSODin is the result of ex-tensive and ongoing research by a group of French scientists dedicated to ageing research, espe-cially as it relates to oxidative stre

Clinical data shows that GliSODin may:

Reduce cellular oxidative damage

Support cellular antioxidant defences

Help maintain healthy blood vessels and cardiovascular health

Serving Type: Vegetable Cellulose Capsule (suitable for vegetarians)

Derived from a specially bred, high antioxidant strain of French Cantaloupe (Cucumis melo), GliSODin boosts the bodys first line of defence against harmful free radicals. Excessive free radicals are a major factor in ageing, inflammation and illness. By stimulating the bodys innate antioxidant defences, GliSODin may help reduce cellular oxidative damage.

• 3.325mg Cucumis melo juice powder (equiv. 3.325g fruit powder)

Adults: Take one capsule twice daily, or as directed by your Health Care Practitioner. Best taken at least 15 minutes before or 2 hours after food.

<p>Each capsule contains 8.3 mg gliadin (a component of gluten), equivalent to the gluten content of a tiny breadcrumb.</p>

<p>Store below 30°C in a dry place. May be refrigerated.</p>

<p>This product contains gluten as an essential component. GliSODin® does not contain palm oil. GliSODin® is GMO free.</p>

<p>NOTE: This product contains genuine trademarked GliSODin® as developed by Laboratories ISO-CELL NUTRA and used as the bioactive material in a number of clinical trials. Quantity of active ingredient is expressed differently according local regulatory requirements.</p>